Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosome biogenesis protein NOP53 (commonly abbreviated as NOP53 and also known as GLTSCR2 or PICT-1) is a nucleolar factor essential for the biogenesis of the 60S ribosomal subunit in eukaryotic cells[1][2]. NOP53 plays a crucial role in integrating the 5S ribonucleoprotein particle into the large ribosomal subunit and participates in rRNA processing and maturation[1][2]. Beyond its direct role in ribosome assembly, NOP53 functions as a nucleolar stress sensor that regulates the tumor suppressor p53/TP53 pathway in response to ribosomal biogenesis perturbation, DNA damage, and cellular stress conditions[2]. It influences cell cycle arrest and apoptosis, partly by stabilizing the tumor suppressors p53/TP53 and PTEN, thereby antagonizing oncogenic PI3K-Akt/PKB signaling[2]. NOP53 has also been implicated as a tumor suppressor, with a role in regulating cell proliferation, apoptosis, and the nucleolar localization/function of proteins such as NPM1 and MYC[2]. No drugs or clinical agents directly targeting NOP53 have been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosome biogenesis protein NOP53 (NOP53).